Otsuka Holdings Co. Ltd

Research Otsuka Holdings Co. Ltd (OS1) on Bullrun: valuation model: 17.4% undervalued, market cap EUR 31.04B, P/E 15.9, dividend yield 1.3%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerOS1
• ExchangeF
• CountryJapan
• SectorHealthcare
• IndustryDrug Manufacturers - General
• CurrencyEUR
• Valuation signal17.4% undervalued
• Market capEUR 31.04B
• P/E15.9
• Dividend yield1.3%
• Financial periodFY2025
• RevenueEUR 2.47T
• Revenue growth6.0%
• Net incomeEUR 363.15B
• Free cash flowEUR 261.91B
• Gross margin71.7%

Valuation Snapshot

Bullrun's latest valuation model marks Otsuka Holdings Co. Ltd as 17.4% undervalued; latest market cap is EUR 31.04B; P/E is 15.9; dividend yield is 1.3%.

About Otsuka Holdings Co. Ltd

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices.

Frequently asked questions

Is Otsuka Holdings Co. Ltd overvalued or undervalued?

Bullrun's valuation model currently marks Otsuka Holdings Co. Ltd as 17.4% undervalued.

What is Otsuka Holdings Co. Ltd's market cap?

Otsuka Holdings Co. Ltd's market capitalization is EUR 31.04B.

What is Otsuka Holdings Co. Ltd's P/E ratio?

Otsuka Holdings Co. Ltd's price-to-earnings (P/E) ratio is 15.9.

Does Otsuka Holdings Co. Ltd pay a dividend?

Otsuka Holdings Co. Ltd has a dividend yield of 1.3%.

What does Otsuka Holdings Co. Ltd do?

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.